GAS5 and hepatocellular carcinoma: Here, we first evaluated the plasma levels of miR-23b-3p in 25 untreated HCC patients and 37 healthy control individuals, as we had already determined the circulating levels of GAS5 and miR-126-3p in the same cohorts [20].